MGC Diagnostics Corporation (MGCD) Issues Quarterly Earnings Results
MGC Diagnostics Corporation (NASDAQ:MGCD) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $0.17 earnings per share (EPS) for the quarter, Bloomberg Earnings reports. MGC Diagnostics Corporation had a positive return on equity of 0.26% and a negative net margin of 10.22%.
MGC Diagnostics Corporation (MGCD) traded up 2.25% during midday trading on Wednesday, reaching $8.19. The company had a trading volume of 6,443 shares. MGC Diagnostics Corporation has a 52 week low of $6.24 and a 52 week high of $10.60. The firm has a 50-day moving average price of $8.03 and a 200-day moving average price of $8.35. The company’s market capitalization is $36.03 million.
TRADEMARK VIOLATION WARNING: This story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another site, it was stolen and reposted in violation of United States and international trademark & copyright law. The original version of this story can be viewed at https://www.thecerbatgem.com/2017/09/06/mgc-diagnostics-corporation-mgcd-issues-quarterly-earnings-results.html.
About MGC Diagnostics Corporation
MGC Diagnostics Corporation is a medical technology company, which offers cardiorespiratory health solutions. The Company designs, markets and sells non-invasive cardiorespiratory diagnostic products. It sells its products internationally through distributors and in the United States through a direct sales force targeting specialists located in hospitals, university-based medical centers, medical clinics, physician offices, pharmaceutical companies, medical device manufacturers and clinical research organizations (CROs).
Receive News & Stock Ratings for MGC Diagnostics Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MGC Diagnostics Corporation and related stocks with our FREE daily email newsletter.